Cite as: 562 U. S. ____ (2011)

3

Opinion of the Court

significant number of parents were already declining
vaccination for their children,10 and concerns about com
pensation threatened to depress vaccination rates even
further.11 This was a source of concern to public health
officials, since vaccines are effective in preventing out
breaks of disease only if a large percentage of the popula
tion is vaccinated.12
To stabilize the vaccine market and facilitate compensa
tion, Congress enacted the NCVIA in 1986. The Act estab
lishes a no-fault compensation program “designed to work
faster and with greater ease than the civil tort system.”
Shalala v. Whitecotton, 514 U. S. 268, 269 (1995). A per
son injured by a vaccine, or his legal guardian, may file a
petition for compensation in the United States Court of
Federal Claims, naming the Secretary of Health and
Human Services as the respondent.13 A special master
then makes an informal adjudication of the petition within
(except for two limited exceptions) 240 days.14 The Court
of Federal Claims must review objections to the special
master’s decision and enter final judgment under a simi
larly tight statutory deadline.15 At that point, a claimant
has two options: to accept the court’s judgment and forgo a
traditional tort suit for damages, or to reject the judgment
and seek tort relief from the vaccine manufacturer.16
Fast, informal adjudication is made possible by the Act’s
Vaccine Injury Table, which lists the vaccines covered
under the Act; describes each vaccine’s compensable,
——————
Lawsuits, and Legal Rights: The Battle over Litigation in American
Society 146 (2002).
10 Mortimer, supra, at 906.
11 See Hagan, 45 Food Drug Cosm. L. J. 477, 479 (1990).
12 See R. Merrill, Introduction to Epidemiology 65–68 (2010).
13 See 42 U. S. C. §300aa–11(a)(1).
14 See §300aa–12(d)(3).
15 See §300aa–12(e), (g).
16 See §300aa–21(a).

